Earlier this season on episode number 088 titled “the Skinny on Skin” we learned about the various skin disorders that can manifest in people with Parkinson’s. Well, on the flip side, the skin is the largest organ in our body. It must hold all kinds of secrets to our health. It turns out alpha-synuclein gets deposited in the skin of patients with synucleinopathies, which includes Parkinson’s and related diseases. Therefore, a skin biopsy can be used to diagnose and confirm these diseases. Not only can this advancement in the diagnosis important, the skin biopsy can also be used to speed up clinical trials. The company leading the way with this procedure and process, CND Life Sciences, has only just getting started. They continue to investigate what the skin can provide clinicians and researches to help bring new therapies to market quicker.
The director of medical affairs for CND and a person with Parkinson’s explains how this all works. Listen on…
https://www.dbsandme.com/en.html
Thank you to my sponsor, Boston Scientific, the maker of Vercise Genus, a Deep Brain Stimulation or DBS system. To learn more about Parkinson’s treatment options, please visit DBSandMe.com.
It is incredible to think that a skin biopsy can determine whether a person has Parkinson’s disease.